Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30352% above fair value
$14.98+0.18 (+1.22%)
Close on Nov 18, 2026Market cap $1.60BP/E –Yield –
Personalis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Personalis's shares outstanding was 105M at Jun 30, 2026. For fiscal 2025 it was 89M, up 50.6% from the year before. The highest annual figure on record is 89M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 89M | +50.6% |
| FY2024 | Dec 31, 2024 | 59M | +23.0% |
| FY2023 | Dec 31, 2023 | 48M | +5.4% |
| FY2022 | Dec 31, 2022 | 46M | +4.1% |
| FY2021 | Dec 31, 2021 | 44M | +27.7% |
| FY2020 | Dec 31, 2020 | 34M | +90.9% |
| FY2019 | Dec 31, 2019 | 18M | +488.0% |
| FY2018 | Dec 31, 2018 | 3M | +1.0% |
| FY2017 | Dec 31, 2017 | 3M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 105M | +19.1% |
| Q1 FY2026 | Mar 31, 2026 | 104M | +19.1% |
| Q4 FY2025 | Dec 31, 2025 | 92M | +26.6% |
| Q3 FY2025 | Sep 30, 2025 | 89M | +45.3% |
| Q2 FY2025 | Jun 30, 2025 | 89M | +68.9% |
| Q1 FY2025 | Mar 31, 2025 | 87M | +72.6% |
| Q4 FY2024 | Dec 31, 2024 | 73M | +46.9% |
| Q3 FY2024 | Sep 30, 2024 | 61M | +25.4% |
| Q2 FY2024 | Jun 30, 2024 | 52M | +9.9% |
| Q1 FY2024 | Mar 31, 2024 | 51M | +8.4% |
| Q4 FY2023 | Dec 31, 2023 | 50M | +7.2% |
| Q3 FY2023 | Sep 30, 2023 | 49M | +6.0% |
| Q2 FY2023 | Jun 30, 2023 | 48M | +4.5% |
| Q1 FY2023 | Mar 31, 2023 | 47M | +3.9% |
| Q4 FY2022 | Dec 31, 2022 | 46M | +3.2% |
| Q3 FY2022 | Sep 30, 2022 | 46M | +3.2% |
| Q2 FY2022 | Jun 30, 2022 | 46M | +3.8% |
| Q1 FY2022 | Mar 31, 2022 | 45M | +6.5% |
| Q4 FY2021 | Dec 31, 2021 | 45M | +15.0% |
| Q3 FY2021 | Sep 30, 2021 | 45M | +25.5% |
| Q2 FY2021 | Jun 30, 2021 | 44M | +38.5% |
| Q1 FY2021 | Mar 31, 2021 | 42M | +34.8% |
| Q4 FY2020 | Dec 31, 2020 | 39M | +24.9% |
| Q3 FY2020 | Sep 30, 2020 | 35M | +13.9% |
| Q2 FY2020 | Jun 30, 2020 | 32M | +381.0% |
| Q1 FY2020 | Mar 31, 2020 | 31M | +914.0% |
| Q4 FY2019 | Dec 31, 2019 | 31M | +918.0% |
| Q3 FY2019 | Sep 30, 2019 | 31M | +915.7% |
| Q2 FY2019 | Jun 30, 2019 | 7M | +115.4% |
| Q1 FY2019 | Mar 31, 2019 | 3M | – |
| Q4 FY2018 | Dec 31, 2018 | 3M | – |
| Q3 FY2018 | Sep 30, 2018 | 3M | – |
| Q2 FY2018 | Jun 30, 2018 | 3M | – |
See a number that looks wrong?